141 related articles for article (PubMed ID: 1056684)
1. Schizophrenia, a disorder of tryptophan metabolism.
Gilka L
Acta Psychiatr Scand Suppl; 1975; 258():1-83. PubMed ID: 1056684
[No Abstract] [Full Text] [Related]
2. [The biochemistry of mental disorders].
Huttunen MO
Duodecim; 1970; 86(24):1409-26. PubMed ID: 4323535
[No Abstract] [Full Text] [Related]
3. Biochemical aspects of schizophrenia.
Lewis ME
Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
[No Abstract] [Full Text] [Related]
4. Schizophrenia, rheumatoid arthritis and trytophan metabolism.
Taylor WM
J Clin Psychiatry; 1978 Jun; 39(6):499-503. PubMed ID: 659373
[TBL] [Abstract][Full Text] [Related]
5. Excretion of indoleamines in schizophrenia.
Bueno JR; Himwich HE
Int J Neurol; 1967; 6(1):65-76. PubMed ID: 5622712
[No Abstract] [Full Text] [Related]
6. [Biochemical and analytical bases of exploration of metabolism of tryptophan].
Lemonnier A; Charpentier C; Leluc R
Ann Pediatr (Paris); 1964 Mar; 11(3):147-55. PubMed ID: 5878703
[No Abstract] [Full Text] [Related]
7. Metabolism and mentation.
Williams RH
J Clin Endocrinol Metab; 1970 Nov; 31(5):461-79. PubMed ID: 4394268
[No Abstract] [Full Text] [Related]
8. [Inadequacy of the monoamine oxidase system--the probable pathogenetic factor in schizophrenia (review)].
Kolpakov VG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1254-63. PubMed ID: 4278558
[No Abstract] [Full Text] [Related]
9. [Tryptophan and its metabolism in schizophrenia].
Szafranek J; Szafranek K
Psychiatr Pol; 1970; 4(5):585-8. PubMed ID: 4921675
[No Abstract] [Full Text] [Related]
10. Editorial: Dimethyltryptamine and psychosis.
Lancet; 1974 Jul; 2(7873):140-1. PubMed ID: 4135558
[No Abstract] [Full Text] [Related]
11. Biochemical aspects of schizophrenia.
Matthysse S; Lipinski J
Annu Rev Med; 1975; 26():551-65. PubMed ID: 1096779
[No Abstract] [Full Text] [Related]
12. [Hypothetical concept: the physiopathological entity of monoaminergic psychoses].
Tissot R
Encephale; 1975; 1(4):289-339. PubMed ID: 1082812
[TBL] [Abstract][Full Text] [Related]
13. Methylation & schizophrenia.
Beaton JM
Ala J Med Sci; 1975 Apr; 12(2):193-202. PubMed ID: 1096652
[No Abstract] [Full Text] [Related]
14. [Endogenous hallucinogens].
Kanabus P; Frindt-Zajaczkowska A
Psychiatr Pol; 1974; 8(2):197-202. PubMed ID: 4830327
[No Abstract] [Full Text] [Related]
15. Implications of catecholamine systems of the brain in schizophrenia.
Matthysse S
Res Publ Assoc Res Nerv Ment Dis; 1974; 53():305-15. PubMed ID: 4155111
[No Abstract] [Full Text] [Related]
16. Biochemical abnormalities associated with schizophrenia.
Smythies JR
Br J Psychiatry; 1975; Spec No 9():41-7. PubMed ID: 1102037
[No Abstract] [Full Text] [Related]
17. [Research into the biochemical bases of schizophrenic syndromes: a review].
Laplante M; St-Laurent J
Union Med Can; 1973 Nov; 102(11):2267-78. PubMed ID: 4134633
[No Abstract] [Full Text] [Related]
18. Biochemical factors in mental retardation.
Hsia DY
Proc Annu Meet Am Psychopathol Assoc; 1967; 56():28-44. PubMed ID: 4966303
[No Abstract] [Full Text] [Related]
19. An enzyme (MAO) defect on the platelets in migraine.
Sicuteri F; Buffoni F; Anselmi B; Del Bianco PL
Res Clin Stud Headache; 1970; 3():245-51. PubMed ID: 5527206
[No Abstract] [Full Text] [Related]
20. Indolealkylamines and behavior.
Airaksinen MM; McIsaac WM
Ann Med Exp Biol Fenn; 1968; 46(3):367-81. PubMed ID: 4896939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
